Researchers are harnessing the power of high-throughput next-generation sequencing (NGS) and microarray technologies to conduct large-scale, global genetic analyses. This research often focuses on multifactorial genetic discovery of disease risk markers, and may involve looking for changes in genetic variants such as single nucleotide polymorphisms (SNPs), indels, splice variants, structural variants, and methylation markers.
High-throughput genomics studies with tens to hundreds of thousands of samples require fast, cost-effective tools. Illumina offers high-throughput sequencing and array technologies with comprehensive sample-to-analysis solutions and exceptional collaborative expertise to meet these needs.
Sequencing by synthesis is a massively parallel sequencing technology that has revolutionized sequencing capabilities and launched the next generation in genomic sciences.
Our high-density microarray technology offers trusted data quality and exceptional coverage of valuable genomic regions, making Illumina arrays the platform of choice by leading institutions for high-throughput screening and large-scale genotyping research programs.
The latest Illumina sequencers unite high-performance imaging with state-of-the-art flow cells to deliver massive increases in throughput. With unmatched scalable throughput, tremendous flexibility for a broad range of applications, and streamlined operation, the NovaSeq 6000 System is the most powerful high-throughput Illumina sequencer to date, perfectly positioned to help scientists perform large-scale genomics studies. The system offers output of up to 6 Tb and 20 billion reads in < 2 days.View System
The Breast Cancer Atlas Project involves sequencing more than a million individual breast cancer cells to help researchers identify potential therapeutic targets.Read Interview
Implementing high-capacity NGS allowed the Deakin Genomics Centre to expand projects for species ancient and new, large and small.Read Interview
A large clinical study that integrates sequencing with imaging, multiomic technologies, and big data uncovers novel therapeutic targets for chronic diseases.Read Interview
Recent advances in sequencing technologies have allowed for the development of high-throughput genomics-based strategies to assay GWAS SNPs for potential functional relevance. Powerful combinations of high-throughput experimental assays, single-cell approaches, and computational analyses are accelerating the ability to link variants to function, and, by extension, link genotype to phenotype.View Webinar
For labs preparing large quantities of NGS libraries, liquid-handling robots and other automation solutions provide a good option.Learn More
Sample multiplexing allows large numbers of NGS libraries to be pooled and sequenced simultaneously during a single run.Learn More
Find information and resources to help simplify the process of setting up an informatics infrastructure and data analysis pipeline.Learn More
Learn how you can benefit from a laboratory information management system (LIMS) optimized for genomics, and find out what to look for.Learn More
Large-scale genotyping with arrays can identify variants associated with disease risk in large cohorts or populations.Learn More
Prenetics created a high-throughput genotyping laboratory to serve its growing customer base in Southeast Asia.Read Article
Researchers discuss large GWAS studies to identify disease-associated DNA risk loci and develop PRSs for clinical validation.Read Article
Resource planning and automated genotyping workflows allowed GPBio to achieve immediate efficiency and throughput gains.Read Article
National population genomics programs seek to integrate large, diverse data sets, combining clinical information with genomic data at scale.Learn More
Genomic technologies are introducing new avenues for understanding complex disease etiology on a molecular level.Learn More
NGS can help pharmaceutical scientists identify potential drug targets and support development of targeted therapies.Learn More